Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides.
BACKGROUND
Differentiating ulcerative colitis (UC) from Crohn's colitis (CC) can be difficult and may lead to inaccurate diagnoses in up to 30% of inflammatory bowel disease (IBD) patients. Much of the diagnostic uncertainty arises from the overlap of clinical and histologic features. Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) permits a histology-directed cellular protein analysis of tissues. As a pilot study, we evaluated the ability of histology-directed MALDI-MS to determine the proteomic patterns for potential differences between CC and UC specimens.


METHODS
Mucosal and submucosal layers of CC and UC colon resection samples were analyzed after histologic assessment. To determine whether MALDI-MS would distinguish inflammation, the uninflamed (n = 21) versus inflamed submucosa (n = 22) were compared in UC and the uninflamed (n = 17) versus inflamed submucosa (n = 20) in CC. To determine whether there were proteomic differences between the colitides, the uninflamed UC submucosa (n = 21) was compared versus the uninflamed CC submucosa (n = 17), the inflamed UC submucosa (n = 22) was compared versus the inflamed CC submucosa (n = 20), and inflamed UC mucosa versus inflamed CC mucosa. Pairwise statistics comparisons of the subsets were performed.


RESULTS
Pairwise comparative analyses of the clinical groups allowed identifying subsets of features important for classification. Comparison of inflamed versus uninflamed CC submucosa showed two significant peaks: m/z 6445 (P = 0.0003) and 12692 (P = 0.003). In the case of inflamed versus uninflamed UC submucosa, several significant differentiating peaks were found, but classification was worse. Comparisons of the proteomic spectra of inflamed submucosa between UC and CC identified two discrete significant peaks: m/z 8773 (P = 0.006) and 9245 (P = 0.0009). Comparisons of the proteomic spectra of uninflamed submucosa between UC and CC identified three discrete significant peaks: m/z 2778 (P = 0.005), 9232 (P = 0.005), and 9519 (P = 0.005). No significantly different features were found between UC and CC inflamed mucosa.


CONCLUSIONS
MALDI-MS was able to distinguish CC and UC specimens while profiling the colonic submucosa. Further analyses and protein identification of the differential protein peaks may aid in accurately diagnosing IBD and developing appropriate personalized therapies.
M'Koma
Amosy E
AE
Department of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, Tennessee 37208-3599, USA. amkoma@mmc.edu
Seeley
Erin H
EH
Washington
Mary K
MK
Schwartz
David A
DA
Muldoon
Roberta L
RL
Herline
Alan J
AJ
Wise
Paul E
PE
Caprioli
Richard M
RM
D015415:Biomarkers / Q000378:metabolism*; D003093:Colitis, Ulcerative / Q000378:metabolism*; D003424:Crohn Disease / Q000378:metabolism*; D016002:Discriminant Analysis; D006801:Humans; D009092:Mucous Membrane / Q000378:metabolism*; D010449:Peptide Mapping; D020543:Proteome / Q000032:analysis*; D040901:Proteomics; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
D015415:Biomarkers; D020543:Proteome
Clin Cancer Res. 2010 Jan 15;16(2):681-90
20068102
J Mol Diagn. 2006 Feb;8(1):51-61
16436634
J Clin Pathol. 2002 Dec;55(12):955-60
12461067
Biochem Pharmacol. 2007 May 1;73(9):1422-33
17258689
J Clin Pathol. 2006 Oct;59(10):1066-72
16565224
Anal Chem. 2004 Mar 1;76(5):87A-93A
15008156
Anal Chem. 2004 Feb 15;76(4):1145-55
14961749
Acta Chir Iugosl. 2000;47(4 Suppl 1):27-31
11432239
Am J Gastroenterol. 2005 Feb;100(2):414-23
15667502
Gut. 1987 Mar;28(3):336-8
3570037
Am J Gastroenterol. 2008 Jan;103(1):162-9
17916108
Gastrointest Endosc. 1987 Feb;33(1):15-7
3557027
Immunity. 2002 Nov;17(5):629-38
12433369
Inflamm Bowel Dis. 2008 Jul;14(7):942-8
18300279
Monogr Pathol. 1977;(18):50-94
611415
J Proteome Res. 2007 Mar;6(3):1114-25
17330946
Curr Gastroenterol Rep. 2003 Dec;5(6):487-92
14602058
Lancet. 2003 Aug 9;362(9382):433-9
12927430
J Postgrad Med. 2009 Apr-Jun;55(2):131-4
19550060
Clin Chem. 2006 Feb;52(2):171-81
16339302
Gastroenterol Clin North Am. 2002 Mar;31(1):21-39
12122733
Inflamm Bowel Dis. 2009 Feb;15(2):284-94
18816633
Ann Stat. 2009 Jan 1;37(5A):2178-2201
19784398
Clin Biochem. 2008 Aug;41(12):960-7
18489908
Gastroenterology. 1980 Jul;79(1):19-25
7380218
Mol Cell Proteomics. 2006 Oct;5(10):1975-83
16849436
Int J Colorectal Dis. 2007 Jun;22(6):581-9
17109102
AJR Am J Roentgenol. 2005 Jun;184(6):1843-7
15908540
N Engl J Med. 2002 Aug 8;347(6):417-29
12167685
BMC Med Genomics. 2010 May 04;3:14
20441585
World J Gastroenterol. 2009 Sep 14;15(34):4234-9
19750566
Pathol Res Pract. 2004;200(2):129-33
15237921
Gut. 1973 Apr;14(4):255-62
4706906
Gut. 2005 Mar;54(3):364-8
15710984
Inflamm Bowel Dis. 2003 Sep;9(5):290-301
14555912